CAR-T Cell Therapy Clinical Trials

43 clinical trials for CAR-T Cell Therapy across international registries, including 21 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Neuropsychological Effects After CAR-T-Cell-Therapy — RECRUITING
• Coping Skills Training for Symptom Management and Daily Steps (Step Up) — RECRUITING · NA
• Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy — RECRUITING
• Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products — RECRUITING
• Exercise as an Immune Adjuvant for Allogeneic Cell Therapies — RECRUITING · PHASE1
• Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients — RECRUITING · PHASE1
• MB-CART2019.1 in Refractory Multiple Sclerosis — RECRUITING · PHASE1
• Nutrition OUtReach In Systems of Healthcare — RECRUITING · NA
• THRIVE-CAR-T Digital App — RECRUITING · NA
• Optimising CAR-T Cell Patient Outcomes by Individualized Supportive Care and Exercise Interventions — RECRUITING
• DALY II Japan/MB-CART2019.1 for DLBCL — RECRUITING · PHASE2
• TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC — RECRUITING · PHASE1
• A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia — RECRUITING · PHASE1
• Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS — RECRUITING · PHASE1
• Anti CD19 CAR-T Combined With BTKi to Treat Newly Diagnosed High-risk CLL/SLL — RECRUITING · NA
• Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia — RECRUITING
• CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia — RECRUITING · PHASE1
• Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE — RECRUITING · PHASE1
• Study of Extracellular Vesicles (EV) in Patients Undergoing CAR-T Cell Therapies — RECRUITING
• GPC3/Mesothelin-CAR-γδT Cells Against Cancers — RECRUITING · PHASE1
• Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers — RECRUITING · PHASE1
• Pre-emptive Anakinra for Cytokine Event Reduction — WITHDRAWN · PHASE1
• A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas — NOT_YET_RECRUITING · PHASE2
• INfections in Patients Treated With CAR-T — NOT_YET_RECRUITING
• Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAV — WITHDRAWN
• Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS — WITHDRAWN · PHASE1
• Functionally Optimized CD33 CAR-T Cell Therapy Targeting Recurrent/Refractory Acute Myeloid Leukemia — NOT_YET_RECRUITING · PHASE1
• Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus — ACTIVE_NOT_RECRUITING · PHASE1
• CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma — NOT_YET_RECRUITING · PHASE1
• Neurological and Cognitive Dysfunction Following CAR-T Treatment. ICANS and Beyond — NOT_YET_RECRUITING
• RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients — NOT_YET_RECRUITING · PHASE4
• Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T Therapy — NOT_YET_RECRUITING
• A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19 — ACTIVE_NOT_RECRUITING
• Sequential CD19/CD22 CAR-T Cell Therapy Following ASCT — COMPLETED · PHASE2
• Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma — NOT_YET_RECRUITING · NA
• CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors — NOT_YET_RECRUITING · PHASE1
• Rehabilitation Needs for Hematologic Cancer Candidate for Hematopoietic Stem Cell Transplantation or CAR T-Cell Therapy — OTHER
• ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy — OTHER
• Patient Reported Outcomes and Patient Education in Cellular Therapy Patients — COMPLETED · NA
• Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester — OTHER · NA
• CAR T-CELL Therapy Educational Video Trial — OTHER · NA
• Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy — OTHER
• An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects — OTHER · PHASE1

Refine this search